Introduction
Retinoids are natural or synthetic derivatives of vitamin A and exert potent growth and dierentiation eects on normal, embryonic and neoplastic cells (Gudas et al., 1994) . Vitamin A (retinol) is essential for vision, reproduction, normal embryonic development, and the regulation of the growth and dierentiation of diverse cell types in adult tissues (Gudas et al., 1994; Zile, 2001) . In addition there is strong evidence for bene®cial retinoid responses in preventing or treating clinical tumors (as reviewed in NasonBurchenal and Dmitrovsky, 1999) .
Mechanisms active in signaling all-trans retinoic acid (RA) eects involve the retinoid receptors: retinoic acid receptors (RARs) and retinoid-X-receptors (RXRs) (Mangelsdorf et al., 1994; Chambon, 1996) . RA regulates gene expression via binding of RA-bound RAR/RXR heterodimers to consensus retinoic acid response elements (RAREs) in the proximal promoter region of RA target genes (Mangelsdorf et al., 1994; Chambon, 1996) . Three RARs (RARa, RARb, and RARg) and three RXRs (RXRa, RXRb, and RXRg) exist and have cell context-dependent expression patterns re¯ecting tissue-speci®c retinoid functions and developmental programs (Mark et al., 1999) . The identity of target genes, which mediate the dierentiation, growth suppressive and antitumorigenic eects of retinoid-activated RARs are largely unknown.
Testicular germ cell tumors (TGCTs) are the most common carcinomas of males between the age of 15 and 35 years (Schottenfeld et al., 1980) . Despite recent progress, the molecular basis for germ cell tumorigenesis is poorly understood (Heidenreich et al., 2000) . Embryonal carcinoma (EC) cells are the stem cell of nonseminomatous TGCTs (Chaganti and Houldsworth, 2000) . In this study, the human TGCT derived EC cell line NT2/D1 was examined. This line was developed from a metastatic lesion of a testicular cancer patient (Andrews, 1998) . Human EC cells, including NT2/D1 cells, appear distinct from murine EC in terms of genetic, phenotypic and biologic markers (Pera et al., 1990; Matin et al., 1998) . Based on these dierences, it has been proposed that NT2/D1 cells may represent an earlier stage of dierentiation compared to most murine EC cells available (Pera et al., 1990; Matin et al., 1998) .
Pluripotent human EC cells are an important model of early human development (Andrews, 1998) . They resemble early embryonic stem cells in morphology, antigen expression patterns, biochemistry, developmental potential, and gene regulation (Andrews, 1998) . NT2/D1 cells are multipotent, dierentiating into well developed, morphologic and immunophenotypic CNS neurons upon culture in RA, with associated loss of cell growth and tumorigenicity (Andrews, 1984; Kurie et al., 1993; Spinella et al., 1999) . The neuron-like cells express the major neuro®lament proteins, a functional glutamate receptor and sodium ion channels. They also form functional synapse and in general possess many of the electro-chemical properties of CNS neurons (reviewed in Andrews, 1998; Przyborski et al., 2000) . Comparisons of human ES, murine ES, and human EC cells have demonstrated that human EC and human ES lines share many phenotypic and morphologic features not possessed by murine ES cells (Thomson et al., 1998; Pera et al., 2000) . Since NT2/D1 cells have been widely characterized, can be propagated without the use of feeder lines or leukemia inhibitory factor (LIF) and can be readily transfected, these cells are a valuable and practical complement to human ES cells as an in vitro model of human embryology. In addition, RA treatment of EC is an important model of tumorigenesis, since RA causes a reversal of the malignant phenotype. However, the genes and pathways regulated during neuronal dierentiation, lineage commitment, and repression of tumorigenic potential of pluripotent EC cells are not well de®ned.
In an eort to identify critical RA-responsive genes during induced tumor cell dierentiation of human EC cells we employed large-scale cDNA microarray technology focused on a series of time points prior to, or concurrent with, commitment of NT2/D1 cells to enter a program of neuronal dierentiation. The results suggest that RA alters the expression of a small dynamic set of regulatory genes at this early stage of lineage commitment. The transcripts identi®ed encode regulatory proteins that are known to play a role in vertebrate neuronal development plus other genes and novel genes not previously associated with this process. While several of the genes are known direct targets of RA, the majority have not been described in this context before. The genes identi®ed are likely candidates in controlling early steps in human development and cellular dierentiation in particular neuronal dierentiation and may also be pertinent to malignant progression of TGCTs and to the clinically relevant antitumor eects of RA.
Results
We sought to identify RA target genes in the human EC cell line NT2/D1. RA treatment of NT2/D1 cells results in G1 arrest of the cell cycle, growth inhibition and terminal neuronal dierentiation (Andrews, 1984; Kurie et al., 1993; Spinella et al., 1998 Spinella et al., , 1999 . Commercial cDNA based microarrays were employed. The array contains 9128 cDNAs representing 8524 unique genes and ESTs. The strategy was to compare mRNA expression from NT2/D1 cells treated with 10 mM RA versus NT2/D1 cells treated with vehicle control, dimethyl sulfoxide (DMSO). Three independent time points were studied; 8 h +/7 RA, 24 h +/ 7 RA, and 48 h +/7 RA. The dose of RA and time points were chosen since previous studies demonstrated that under these conditions NT2/D1 cells will commit to dierentiate within 24 ± 48 h (Andrews, 1984; Spinella et al., 1999) . Each RA time point was harvested and hybridized on independent days and each time point was matched to an individual vehicle (DMSO) control. Dierences in gene expression between DMSO and RA treated mRNA populations was compared by scatter plot analysis (Figure 1 ), similar to the recent analysis of Kelly and Rizzino, 2000. In this representation, each point represents a particular gene. The location of the point is determined by the Cy3 probe intensity value generated from the vehicle treated mRNA population represented by the x-axis with its Cy5 probe intensity value of the RA treated mRNA population represented by the y-axis. In each plot, points that lie close to the linear regression line represent genes that are expressed at similar levels in the two RNA populations. The distance that a gene lies along the regression line represents its level of expression in relation to other genes. The perpendicular distance that a gene lies from the regression line denotes the degree of its dierential expression between the DMSO and RA treated samples.
This analysis reveals a very tight distribution pattern along the linear regression line of the data points, indicating that expression of the majority of genes are unchanged with RA treatment. Fold-changes of 1.7-, 1.8-and 1.8-fold or higher were chosen to represent changes above background for the 8, 24 and 48 h time points, respectively. These cutos are represented as parallel lines from the central, linear regression line in Figure 1 . Under these criteria a total of 94 genes were regulated by RA (57 induced and 37 repressed). The percentage of cDNAs regulated for each experiment was 0.27% (22 induced/two repressed out of 9036) at 8 h; 0.55% (31 induced/18 repressed out of 8917) at 24 h and 0.77% (40 induced/24 repressed out of 8264) at 48 h. Figure 1 also demonstrates that the number of RA mediated changes in gene expression is severely restricted at 8 h with a bias toward genes induced by RA. The total number of RA-responsive genes increases at 24 and especially 48 h and their pattern of expression is more symmetrical.
The identity and associated function of each gene is provided in Table 1 . Genes were clustered according to their temporal expression patterns in response to RA (Figure 2 and Table 1 ). While several of the genes have been previously shown to be RA-regulated, the majority have not been previously associated as RA targets (see Table 1 ). We noticed that many of the same genes were highly ranked in all three experiments but sometimes just missed the 1.7, 1.8, 1.8 standard. To provide information on the trends of gene expression, fold-changes of 1.5-, 1.6-and 1.7-fold are included for the 94 genes in Table 1 . These values still represent less than 3% of the genes for each experiment and are nonbolded in Table 1 . This reveals that 27 genes were upregulated by RA at 8 h and ®ve repressed. Many of the same genes remain induced at 24 ± 48 h with the total number of regulated genes increasing (53 induced and 36 repressed).
Functional categorization of the genes reveals that many of the acutely induced genes are associated with development, retinoid metabolism, cell signaling and growth suppression (Table 2 ). These include extracellular signaling molecules and their receptors, transcription factors, and second messenger signaling modi®ers. A larger percentage of the genes induced later (at 24 and 48 h) are involved in matrix remodeling, cell adhesion and regulation of the cytoskeleton (Table 2 and Figure 2 ). The majority of repressed genes are associated with protein/RNA processing, turnover or metabolism. In addition, several uncharacterized or partially characterized ESTs of unknown function were identi®ed as regulated by RA in NT2/D1 cells (Table 2) .
Thus far 22 of 24 genes have been con®rmed by RT ± PCR indicating a very low level of false positives ( Figure 3 , Table 1 and data not shown). Furthermore the kinetics of induction predicted by the array analysis was con®rmed for many of the genes. For example, SFRP1 was con®rmed to be repressed with RA treatment beginning at 24 h. Induction of IGFBP3 and MMP11 did not commence until 24 and 48 h, respectively. Chimerin 2, ESTAA251635, HAS2, CNR1, NRP1, BTG2 and SDR1 were con®rmed to be induced within 8 h ( Figure 3 ).
Discussion
Extensive knowledge exists in regard to the molecular interactions occurring during nuclear receptormediated target gene activation (Edwards, 1999; Glass and Rosenfeld, 2000) . However, the identity of all but a few of the target genes of retinoic acid receptors remains undiscovered. The current study has identi®ed a variety of regulatory genes, which are candidate targets of RA during induced tumor cell dierentiation of human EC cells. Since these genes are regulated by RA during the commitment phase of NT2/D1 neuronal dierentiation, it is likely that many play a regulatory role in promoting neuronal dierentiation, suppressing stem cell renewal and growth, and directly mediating the antitumor eects of RA in this model. It should be noted that NT2/D1 cells are particularly informative as compared to other dierentiation models since commitment to dierentiation occurs with a single agent, RA, without additional specialized conditions such as serum starvation, application of mitotic inhibitors or cAMP, or con¯uent growth and aggregation (Andrews, 1984; Spinella et al., 1999) .
A total of 57 distinct transcripts were induced and 37 repressed by RA. At the early 8 h time point the expression of many more genes were induced than a b c Figure 1 Scatter plot analysis comparing expression data from vehicle (DMSO) and RA treated NT2/D1 cells. For each experimental time point, individual genes were plotted using the log of the non-normalized signal intensity for Cy3 and Cy5 probes. The y-axis represents the Cy5 probe signal generated from RA-treated cells. The x-axis represents the Cy3 probe signal generated from vehicle (DMSO) treated control. The thick line is the linear regression line. Points above this line represent genes induced by RA and genes below the line represent genes repressed by RA. The cutos used are indicated by thin lines repressed. This is consistent with RARs being direct inducers and not direct repressors of transcription. These distributions become more symmetrical at 24 and 48 h and may represent a second wave of gene regulation mediated by the early induced genes. Several of the genes have been previously shown to be direct targets of RARs, in EC and other cell contexts and include LeftyA, CYP26A1, CRABP2, Meis2, HoxD1, midkine, Gbx2 and neurogranin (see Table 1 ) (OuladAbdelghani et al., 1997 (OuladAbdelghani et al., , 1998 White et al., 1997; Durand et al., 1992; Simeone et al., 1990; Michikawa et al., 1993; Bouillet et al., 1995a; Iniguez et al., 1994) . This supports the validity in using cDNA microarray analysis to identify RA targets in EC cells. The majority of genes have not been previously associated as RA inducible and thus may play previously unrecognized roles in mediating RA eects in EC cells. Four genes that are induced within 8 h (CYP26A1, CRAPB2, short-chain-dehydrogenase/reductase 1, and the corepressor RIP140) are associated with modulation/attenuation of retinoid-signaling (White et al., 1997; Durand et al., 1992; Haeseleer et al., 1998; Lee and Wei, 1999) . We have recently shown that RIP140 is a primary, cycloheximide insensitive, target of RARs in NT2/D1 and MCF-7 cells and that RIP140 in turn represses RAR activity in these cells (Kerley et al., 2001) . Thus, an early-programmed response to RA in NT2/D1 cells appears to be modulation of the RA signal itself.
Many of the early induced genes are known to be associated with development and in many cases neuronal development. Surprisingly, in this cell autonomous dierentiation model, many genes involved in cell-cell communication, patterning, and fate determination are regulated by RA. These include developmental pathways such as TGF-b (LeftyA, NMA, follistatin), homeo domain (HoxD1, Meis2, Mesi1, Gbx2) IGF (IGFBP3, IGFBP6, CTGF), Notch (manic fringe, ADAM11), Hedgehog (patched) and Wnt (Frat2, secreted frizzled-related protein 1) signaling. (For recent reviews of these pathways see Schier and Shen, 2000; Cillo et al., 2001; Allan et al., 2001; Mumm and Kopan, 2000; Taipale and Beachy, 2001; Altmann and Brivanlou, 2001 ). This suggests multiple signals from diverse signaling pathways are involved in the maintenance of stem cell renewal and subsequent RA-induced lineage commitment of human EC. Interestingly, gp130, a receptor component of c-kit and LIF, two ligands associated with stem cell renewal (Nichols et al., 2001) , is induced by RA. The data not only indicates which pathways may be involved but suggests how RA, a known morphogen critical for development, reprograms the dynamic balance of these pathways by altering the transcription of speci®c pathway components. Alternatively, although the major cell type to emerge from RA treated NT2/D1 cells are neurons, the regulation of the diverse pathway genes seen here may represent the early emergence of multiple cell types in the NT2/D1 culture. Deregulation of developmentally related genes has been associated with tumorigenesis (Calvo and Drabkin, 2000; Taipale and Beachy, 2001) . A large cassette of genes upregulated at 24 ± 48 h are associated with matrix remodeling and cell adhesion. These include members of the serpin family of serine protease inhibitors, MMP11, integrin alpha-4, the cell adhesion proteins Claudin 10 and OSF-2, and secreted matrix proteins osteopontin and collagen type 1 (Janciauskiene, 2001; Basset et al., 1990; Takada et al., 1989; Morita et al., 1999; Takeshita et al., 1993; Kiefer et al., 1989) . This implies that a substantial remodeling of the extracellular matrix takes place during the early phase of induced dierentiation of NT2/D1 cells. Other upregulated genes are associated with intercellular signaling (see Table 2 ). In general, few of the genes upregulated by RA are structural, metabolic or housekeeping genes. In contrast, the majority of downregulated genes are associated with protein/RNA processing, turnover or metabolism. This suggests a shutting down of cellular activity during the transition to a postmitotic state established to commence approximately 48 h after RA treatment of NT2/D1 cells (Spinella et al., 1999) .
The limited number of global expression studies reported utilizing NT2/D1 cells or murine ES cells show minimal overlap with the RA-regulated genes found here (Satoh and Kuroda, 2000; Bani-Yaghoub et al., 2001; Leypoldt et al., 2001; Kelly and Rizzino, 2000) . This is perhaps due to a focus on gene expression of end-stage neuronal cells which require prolonged RA treatments (up to several weeks) and/or addition of mitotic inhibitors to purify neuronal cells from undierentiated cells. In addition, these studies utilized smaller-scale expression arrays containing fewer than 600 genetic elements. In contrast, Bouillet et al. (1995b) identi®ed 12 early RA-induced genes using a subtractive hybridization technique in murine P19 EC cells. Three of these genes LeftyA, Gbx2, and Meis2 were likewise identi®ed as early RA-responsive genes in the current study.
RA induces G1 cell cycle arrest and growth suppression of NT2/D1 cells (Andrews, 1984 , Spinella et al., 1999 . Several genes identi®ed in the current study may potentially contribute to this response. Genes associated with antiproliferation that are induced within 8 h of RA treatment include CHN2, BTG2 and HGS while IGFBP3 and IGFPB6 which repress mitogenic IGF signaling are induced by RA at later time points. CHN2, chimerin 2 (beta-2-chimerin) Figure 2 Hierarchical cluster analysis of temporal expression pro®le of RA-regulated genes. The 94 genes which demonstrated RA regulation equal to or higher than 1.7, 1.8, and 1.8, at 8, 24 or 48 h respectively, were hierarchical clustered for similarity. The cluster image shows the trend in gene expression over time. Green represents genes repressed with RA at a given time point. Red represents genes induced with RA at a given time point. The greater the color intensity the greater the fold-change. Black represents no change with RA de®ned as below the level of 1.5. Grey represents an uninformative data point due to failure to meet probe selection criteria as described in Materials and methods is a GTPase activating protein (GAP) speci®c for the inactivation of p21-rac and is downregulated in highgrade gliomas compared to normal brain and lowgrade astrocytomas (Yuan et al., 1995) . HGS, HGFregulated tyrosine kinase substrate, is associated with a suppression of cytokine-induced cell growth (Asao et al., 1997) . BTG2 is a p53 target gene associated with negative cell cycle regulation (Rouault et al., 1996) . In contrast, a pro-apoptotic p53 target gene, Noxa, is repressed by RA, which could contribute to the Histamine-releasing factor Phosphoinositide-3-kinase, class 3
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Genes in bold type are induced with RA. Genes in non-bold type represses with RA. (*) Represents genes regulated within 8 h of RA treatment. (N) Represents genes associated with neuronal development or neuronal dierentiation survival of postmitotic, NT2D1 cell-derived neurons (Oda et al., 2000) . TGCTs rarely possess p53 mutations, which has been associated with the high cure rate of TGCT patients in response to cisplatinbased therapy (Peng et al., 1993; Heimdal et al., 1993) . We have previously shown that in NT2/D1 but not cisplatin-and RA-resistant NT2/D1-R1 cells, RA activates the transactivation function of p53 (Curtin et al., 2001) . Based on these ®ndings, we proposed RA regulation of a subset of target genes is through activation of p53 which contributed to G1 arrest and subsequent dierentiation (Curtin et al., 2001) . Other p53 targets highlighted as regulated by RA in this study besides Noxa and BTG2 are IGFBP3 and IGFBP6 (Buckbinder et al., 1995; Kannan et al., 2001 ). It will be of interest to discover whether a larger subset of p53 targets are regulated by RA and to what extent this pathway contributes to RA-mediated gene regulation.
We noticed compression of the array data. For many of the genes, the array analysis underestimated the fold-induction seen via subsequent Northern or RT ± PCR analysis (data not shown). The reason for this is unclear, however, compression is a common ®nding with array expression studies (for example, as reported by Chang et al., 2000) and may be related in part to dierences in hybridization stringency between Northern and microarray analyses. Furthermore, additional known or suspected RA target genes were consistently shown to be induced by RA across array experiments but had a fold-induction that were below the cuto thresholds used here. These genes when ranked by foldinduction, are still within the top 2 ± 3% of all the genes of a given array experiment. The entire expression data sets will be freely available upon request from the authors. An additional noted peculiarity was that several genes known to be highly induced by RA in NT2/D1 cells did not score positive in the array experiments. Thus, it is likely that the 94 genes identi®ed here represent a subset of the RAregulated genes contained on each array.
Despite recent progress, the molecular basis for germ cell tumorigenesis with regard to alterations in tumor suppressor genes or oncogenes is poorly understood. However, most TGCTs have an increased copy number of 12p, either in the form of multiple copies of i(12p) or as tandem duplications of 12p (Dmitrovsky et al., 1990; Chaganti and Houldsworth, 2000; Heidenreich et al., 2000) . Further, this chromosomal abnormality is present in the early premalignant carcinoma in situ lesions of TGCT patients (Vos et al., 1990) . This suggests that overexpression of a gene within 12p may drive tumorigenesis of TGCTs. Interestingly, two of the genes which are repressed by RA in the present study, mannose-6-phosphate receptor and inositol 1,4,5-triphosphate receptor 2, reside on 12p (Pohlmann et al., 1987; Yamamoto-Hino et al., 1994) . Since RA has potent eects in reversing the tumorigenic properties of NT2/D1 cells these genes may have a role in contributing to the malignant potential of TGCTs.
In summary, we have identi®ed a cassette of regulatory genes whose expression is acutely altered during the initial events of RA induced terminal dierentiation of human EC cells. The majority of the genes have not been previously implicated as RA targets. We propose a role for these genes in mediating the dierentiation, growth suppressive and antitumorigenic eects of RA. In addition, the results of these in vitro studies may provide insight into normal human development and cancer. Much work needs to be done to de®ne the physiologic or pharmacologic importance of these genes in normal development and retinoidbased cancer therapy or prevention.
Materials and methods

Cell culture, induction protocol and RNA isolation
The RA-sensitive human EC cell line, NT2/D1 is a clonal line derived from a xenograft of Tera-2 cells (Andrews, 1998) . Cells were cultured in high glucose DME with 10% fetal bovine serum supplemented with penicillin, streptomycin, and glutamine under humidi®ed 5% CO 2 . The RA induction protocols were as follows. On day-2 cells in log phase growth Figure 3 Eect of RA on transcript levels of selected genes in NT2/D1 cells. RT ± PCR analysis depicting time course (in hours) of indicated genes in response to 10 mM RA or DMSO vehicle control in NT2/D1 cells. RT ± PCR analysis was performed on independent samples from those used in array experiments. Regulation of indicated mRNA transcripts by RA is similar to that predicted by cDNA expression arrays. In indicated samples (7RT) reverse transcriptase was omitted to control for genomic DNA contamination were plated in DME media with 10% charcoal absorbed serum to deplete endogenous serum retinoids. 1610 6 cells were plated per 15-cm dish to assure that cells would not reach con¯uence during the experiment. On day 0, medium was replaced with fresh medium containing 10 mM RA or the vehicle, DMSO. Cells were harvested for RNA isolation 8, 24 or 48 h later. Each RA time point had a matching DMSO control. RA was stored under liquid N 2 in the dark as a 10 mM stock solution dissolved in DMSO. Total RNA was isolated using TriReagent (Invitrogen Life Technologies). Poly A + RNA was isolated from a minimum of 500 mg of total RNA using the Oligotex mRNA midi kit (Qiagen) according to manufacturer's recommendations. Poly A + RNA was monitored for integrity on denaturing formaldehyde gels. As a further quality control, semiquantitive PCR using primers for a known RA target gene, retinoic acid receptor b (RAR-b), was performed to con®rm RA gene induction (RAR-b sense primer-TGC CAA CCA GCT CCT GCC TTT and antisense primer-GCC ATT GAT CCA GGA ATT TCC A). Ampli®cation was performed using recombinant Taq DNA polymerase (Invitrogen Life Technologies) according to the manufacturer's instructions for 25 cycles.
cDNA array hybridization and gene expression analysis cDNA probe synthesis, hybridization and signal analysis were conducted by Incyte Genomics (St. Louis, MO, USA) as described on the company's website, http://www.incyte.com. The cDNA-based Human Unigene 1 Life array was employed. This array is 100% sequence veri®ed and contains 9128 independent clones representing 8524 unique genes and ESTs. Initial data analysis was performed using GemTools 2.4. In all cases, cDNA generated from RA treated samples were labeled with Cy5 while matching DMSO controls were labeled with Cy3. All reported fold-changes are normalized balanced dierential expression. Spots on the array in which either probe failed selection criteria as de®ned by Incyte were discarded prior to analysis. As described in the text, the cutos for balanced dierential expression (fold-change) between Cy3 and Cy5 probes used were 1.7, 1.8 and 1.8 for the 8, 24 and 48 h experiments, respectively. Cluster analysis was performed only on those genes that met the above cuto for at least one time point. Hierarchical clustering was performed with an euclidean metric for similarity using the Cluster program by Michael Eisen (Eisen et al., 1998) and Xcluster by Gavin Sherlock (modi®ed by RH Gross). This software is available from the Stanford MicroArray Database site, http://genome-www5.standofrd.edu/MicroArray/SMD/ restech.html. The clustered data was visualised using TreeView (Eisen et al., 1998) .
RT ± PCR analysis
Expression levels of several genes in response to RA were measured by semi-quantitative RT ± PCR. RNA samples were independently generated from those used in array experiments for use in RT ± PCR analysis. The cDNA was synthesized from 5 mg total RNA using Superscript II reverse transcriptase (GIBCO-BRL), as previously described (Spinella et al., 1998; Curtin et al., 2001 ). Ampli®cation of highlighted array genes and b-actin was performed using Taq polymerase as described previously (Curtin et al., 2001) . Experiments were performed to determine the optimal number of cycles that would yield linear phase of ampli®ca-tion, which ranged from 17 to 30 cycles. PCR products were resolved on a 1.5% agarose gel stained with ethidium bromide. Ampli®cation of actin cDNA was used as a normalizing control and reverse transcriptase was omitted from select samples to control for genomic DNA contamination. For certain products detection in the linear range required transfer to nitrocellulose and probing with a radiolabeled internal primer. Primers were chosen from the veri®ed sequence of each cDNA clone to yield a product of 200 ± 300 bp. Sequence of PCR primers are available upon request. As reported in Table 1 , in select cases Northern and Western analysis were performed by standard methods as described previously (Curtin et al., 2001; Kerley et al., 2001) .
